MedTrace Logo

Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia

NCT02467257 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2015-06-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether Gum Arabic is effective as fetal hemoglobin inducing agent for sickle cell anemia patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Gum Arabic

oral ingestion of 30 gram every day for 12 weeks

Sponsors & Collaborators

  • Military hospital

    collaborator UNKNOWN

  • Ministry of Higher Education and Scientific Research, Republic of Sudan

    collaborator OTHER_GOV

  • Al-Neelain University

    lead OTHER

Principal Investigators

  • Amal M Saeed, PhD · University of Khartoum Faculty of Medicine Department of Physiology

  • Lamis AA Kaddam, MSc · Department of physiology Faculty of Medicine Alneelain University Khartoum,

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Sudan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02467257 on ClinicalTrials.gov